Meeder Advisory Services’s Pfizer PFE Stock Holding History

Meeder Advisory Services’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.66M	Sell	110,339 -6,361	-5%	-$166K	0.1%	137
2026 Q1	$3.28M	Buy	116,700 +17,764	+18%	+$473K	0.14%	102
2025 Q4	$2.46M	Buy	98,936 +5,294	+6%	+$134K	0.11%	129
2025 Q3	$2.39M	Buy	93,642 +14,032	+18%	+$346K	0.11%	132
2025 Q2	$1.93M	Buy	79,610 +19,588	+33%	+$457K	0.1%	152
2025 Q1	$1.52M	Sell	60,022 -196	-0.3%	-$5.13K	0.09%	175
2024 Q4	$1.6M	Sell	60,218 -1,566	-3%	-$42.5K	0.1%	155
2024 Q3	$1.79M	Buy	61,784 +1,503	+2%	+$43.8K	0.12%	143
2024 Q2	$1.69M	Buy	60,281 +12,208	+25%	+$336K	0.12%	142
2024 Q1	$1.33M	Sell	48,073 -2,041	-4%	-$56.6K	0.14%	130
2023 Q4	$1.44M	Sell	50,114 -10,003	-17%	-$302K	0.17%	107
2023 Q3	$1.99M	Sell	60,117 -9,160	-13%	-$324K	0.25%	64
2023 Q2	$2.54M	Sell	69,277 -2,558	-4%	-$99.6K	0.27%	58
2023 Q1	$2.93M	Sell	71,835 -4,118	-5%	-$178K	0.34%	47
2022 Q4	$3.89M	Buy	+75,953	New	+$3.64M	0.49%	34

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Meeder Advisory Services's PFE Position: Q2 2026 in Review

Meeder Advisory Services reduced its Pfizer (PFE) stake by 5.5% in Q2 2026, selling an estimated $166K and leaving 110,339 shares worth $2.66M. The position accounts for 0.1% of the portfolio, ranked #137.

Meeder Advisory Services first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.89M in Q4 2022. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Meeder Advisory Services held 110,339 shares of Pfizer worth $2.66M as of Q2 2026.
Meeder Advisory Services sold 6,361 Pfizer shares in Q2 2026, an estimated $166K.
Pfizer made up 0.1% of Meeder Advisory Services's portfolio in Q2 2026, its #137 holding.
Meeder Advisory Services first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
Meeder Advisory Services's Pfizer position peaked at $3.89M in Q4 2022.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.